Table 3.
Detailed characteristics of students diagnosed high-risk CKD cases
| Diagnosis | Age (years) | Sex | 1st Urinalysis | 2nd Urinalysis | eGFRcreat | Treatment | |||
|---|---|---|---|---|---|---|---|---|---|
| Protein | OB | Protein | OB | Uprot/Ucr ratio | [mL/min/1.73m2] | ||||
| IgA nephropathy | 6 | F | - | 3 + | + | 3 + | 0.15 | 132.80 | PSL + MZ + CyA + warfarin + dipyridamole |
| IgA nephropathy | 7 | M | 3 + | 3 + | 3 + | 3 + | 2.64 | 99.45 | PSL + MZ + warfarin + dipyridamole + ACEI |
| Membranoproliferative glomerulonephritis | 10 | F | – | + | 3 + | 3 + | 1.11 | 84.76 | PSL + MMF + CyA + ACEI + CCB |
| Focal/segmental glomerulosclerosis | 12 | M | 2 + | – | 3 + | – | 1.31 | 118.77 | PSL + ACEI + ARB + CCB |
| Nephrotic syndrome (renal biopsy is not performed) | 8 | M | 2 + | – | 3 + | – | 3.00 | 134.60 | PSL + MZ |
| Nephrotic syndrome (renal biopsy is not performed) | 13 | M | 3 + | – | 3 + | – | 3.21 | (Another hospital) | |
| Autosomal dominant polycystic kidney disease | 12 | M | * | * | 3 + | – | 2.02 | 119.08 | (Close observation) |
CKD chronic kidney disease, eGFRcreat estimated glomerular filtration rate that calculated from creatinine, OB occult blood, Uprot/Ucr ratio urinary protein/creatinine ratio, PSL prednisolone, MZ mizoribine, CyA cyclosporine, ACEI angiotensin-converting-enzyme inhibitor, MMF mycophenolate mofetil, CCB calcium channel blocker, ARB angiotensin receptor blocker
*Not submitted